CNBS News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

CN

Volume

4.65K

Loading chart

CN

CNBSAmplify Seymour Cannabis ETF

CNBS

Pay with—

Available Balance0.00

CN

AUM

N/A

Volume

4.65K

Yield

3.92%

Chart Earnings News About Insider Filings

1 Major Reason Cannabis Stocks Surged This WeekMarijuana stocks experienced significant gains after Donald Trump's video promoting hemp-derived CBD benefits and potential marijuana reclassification, with several cannabis companies and ETFs seeing notable price increases.The Motley Fool · Oct 1, 2025

EXCLUSIVE: Emotional Connection With Consumers Is Secret Sauce For Any Brand To Prosper, It's Same With Cannabis, Experts SayExperts say that fostering emotional connections with consumers is crucial for a brand's success, including in the cannabis industry. Understanding consumer needs and providing consistent, quality products are key to building customer confidence and loyalty.Benzinga · Oct 14, 2024

Victory In Commerce Clause Case Could Be The Silver Bullet For Cannabis Industry, Experts SayExperts discuss the potential impact of a victory in a commerce clause case on the cannabis industry, suggesting it could be a 'silver bullet' by addressing issues like tax deductions and banking access.Benzinga · Oct 8, 2024

Here's Why Tilray Brands Has Become a Much Better Buy Than Canopy GrowthTilray Brands and Canopy Growth have taken different approaches in their growth strategies. Tilray has expanded into alcohol, which has improved its financials, while Canopy Growth has remained focused on the U.S. cannabis market. Tilray appears to be the better investment, but both stocks are still considered risky.The Motley Fool · Aug 14, 2024

Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth'Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is renowned for recognizing the potential of the cannabis sector early on. In an exclusive interview with Benzinga Cannabis, he discussed the critical role of strategic partnerships in expanding market reach, the importance of operational efficiencies in improving gross margins and the potential of the U.S. hemp cannabinoid market as a burgeoning and legally complex segment poised for substantial growth. These insights are vital for investors looking to understand the dynamics that drive profitability and growth in the cannabis industry. “Cannabis sector growth continues to exceed expectations, particularly as regulations begin to soften worldwide. This shift is creating significant investment opportunities,” Seymour told Benzinga. He underscored the dynamic nature of the market, fueled by regulatory changes that often catalyze growth and investor interest. Investment Strategy And Portfolio Management In managing the $CNBS ETF, Seymour employs a selective strategy that prioritizes companies with robust governance structures and strong market potential. “In a nascent industry like cannabis, governance and strategic foresight are paramount. We focus on companies that are not only well-managed but also poised for growth. "We specifically look at leaders like Curaleaf (OTC: CURLF), which is renowned for its expansive operational footprint and ...Full story available on Benzinga.comBenzinga · Jun 17, 2024

Best ETF Areas of Last WeekWall Street was upbeat last week. The Fed's plan to slower the balance sheet tightening process and the release of downbeat jobs data dragged down bond yields.Zacks Investment Research · May 7, 2024

Is Rescheduling a Certainty for Cannabis? ETFs That SurgeIn a White House meeting, Vice President Kamala Harris this week urged the DEA to expedite the rescheduling of marijuana. President Biden also lately talked about ongoing efforts to review the federal classification of marijuana, hinting at his commitment to potential reformsZacks Investment Research · Mar 22, 2024

Cannabis ETFs Jump on Imminent Rescheduling NewsCannabis stocks & ETFs jumped on Mar 15 after a prominent hedge fund manager suggested that regulators will soon reclassify marijuana as a less dangerous drug.Zacks Investment Research · Mar 18, 2024

Cannabis Stocks & ETFs: Can the Recent Surge Continue?CNBC's cannabis expert Tim Seymour discusses the outlook for the industry.Zacks Investment Research · Sep 18, 2023

Behind the Recent Surge in Marijuana ETFsIn a significant development, the Department of Health and Human Services (HHS) has recently initiated a review of marijuana's classification under the Controlled Substances Act.Zacks Investment Research · Sep 11, 2023

to start trading

CN

CNBSAmplify Seymour Cannabis ETF

CNBS

Pay with—

Available Balance0.00

Your PositionYou don't own any CNBS yet.

Related Tickers

Earnings